Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy

Li Li; Jinghao Duan; Yongsheng Gao; Ying Yin; Fengchang Yang; Wenjie Tang; Xiaoyu Song; Tao Hu; Jinfeng Cui; Jinming Yu; Shuanghu Yuan

doi:10.1002/ctm2.1522

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1522 DOI: 10.1002/ctm2.1522

LETTER TO THE JOURNAL

Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy

Author information +

History +

PDF

Cite this article

Download citation ▾

Li Li,Jinghao Duan,Yongsheng Gao,Ying Yin,Fengchang Yang,Wenjie Tang,Xiaoyu Song,Tao Hu,Jinfeng Cui,Jinming Yu,Shuanghu Yuan. Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy. Clinical and Translational Medicine, 2024, 14(1): e1522 DOI:10.1002/ctm2.1522

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cancer.Net. Lung Cancer-Small Cell: Statistics. 2021. Available at:

[2]	Remon J, Aldea M, Besse B, et al. Small cell lung cancer: a slightly less orphan disease after immunotherapy. Ann Oncol. 2021;32:698-709.

[3]	Amarasena IU, Chatterjee S, Walters JA, Wood-Baker R, Fong KM. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev. 2015;2015:CD006849.

[4]	Subhayan Das MK, Bikash Chandra J. Chapter 25: Causes of cancer: physical, chemical, biological carcinogens, and viruses. In: Subhas C, Kundu RLR, eds. Biomaterials for 3D Tumor Modeling. 2020:607-641.

[5]	Samer Ayoubi IFD, Al-Mefty O. 31-Meningiomas. In: Andrew H, Kaye ERL, eds. Brain Tumors. 3rd ed. 2012:600-629.

[6]	Aerts HJ. The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol. 2016;2:1636-1642.

[7]	Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16:385-395.

[8]	Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252-7259.

[9]	Li L, Tang S, Yin JC, et al. Comprehensive next-generation sequencing reveals novel predictive biomarkers of recurrence and thoracic toxicity risks after chemoradiation therapy in limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys. 2022;112:1165-1176.

[10]	Bodalal Z, Trebeschi S, Nguyen-Kim TDL, Schats W, Beets-Tan R. Radiogenomics: bridging imaging and genomics. Abdom Radiol. 2019;44:1960-1984.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.